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Abstract : BACKGROUND : Dexmedetomidine has analgesic and anesthetlC sparing effects.
Accumulating evldence indicates that intrathecal and epldural neostigmine results in antinocice-
ptive effects postoperatively. The purpose of this study is to investigate whether co-administra-
tion of lntraOPerative systemic dexmedetomidine and epidural neostigmine produces the
postoperative analgesic effects,
METHODS : 60 patients undergoing lower abdominal surgery were randomly divided into four
groups as follows ; control (group C), neostlgmine (group N), dexmedetomidine (group D), and
both neostigmineand dexmedetomidine (group ND), In group C and group D, 10ml ofO.375%
ropjvacaine was admlnistered epiduraHy, while 0.3 mg neostlgmine was added to the 0.375%
ropivacalne in group N and group ND. When the general anesthesia was induced, ln group D
and group ND. dexmedetomidine was started and continued at 0,4/Jg/kg/hr until the end of
surgery, The pain status of patlentS Was aSSeSSed by using Visual Analog Scale (VAS) at 2. 4,
6, 24 and 72 h postoperatively.
RESULTS : The co-adminIStration of systemic dexmedetom'rdine and epidural neostigmine
significantly decreased the VAS scores at 2 h after the surgery, although the intraoperatlVe
systemic infusion of dexmedetomidine alone did not reduce the postoperative VAS scores.
CONCLUSlONS : The co-admlnlStration of systemic dexmedetomidine and epidural neostigmine
produced the analgesic effects. however, these effects were very short-lasting and lnSufficient･
These results suggest that alternative approaches such as the higher doses of co-administrat10n
of dexmedetomidine and neostigmine may Improve POStOPerative paln Status.
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lNTRODUC¶ON
Dexmedetomidine, a specific a2-reCePtOr agOnist, has both sedative and analgesic-sparlng PrOPertiesl･2)･
Analgesic effects of dexmedetomidine were reported when uslng a computer-COntrOHed thermode to deliver
painful heat stimuli in human volunteer studies3). lntraoperative>infusion of dexmedetomidine was found to
reduce postoperative morphine requlrement after major inpatient surgery4) and total abdominal hysterectomy5).
The peripheral nerve injury and consequent inflammatory responses produced by surglCal procedures
result in a compIICated paln reSPOnSe6) which are difficult to treat with conventional analgesics such as opioids
and non-steroidal antトinflammatory drugs, but may respond to other classes of analgesics such as a2-
adrenerglC agOnists7), tricyclic antidepressants8) and neostigmine9･10)
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We previously demonstrated that co-administration of systemic dexmedetomidine and epidural neostig一
mine resulted in transient analgesic effects only ln late postoperative periods under basal epidural administration
of ropivacaine at relatively high dose (0.75%)ll). Our previous unsatisfactory ｢esults prompted us to seek an
alternative approach･ We speculate that lowerlng the Local anesthetic concentration used for basal epidural
anesthesia might emphasize the effects of co-administration of systemic dexmedetomidine and epidural
neostigmine･ Therefore, we investigated here whether co-administration of intraoperative systemic dex-
medetomidine and epidural neostigmine produces postoperative analgesic effects in early periods as well as
those in late periods under basal epidural administration of ropivacaine at relatively low doses (01375%)･ ln
patients undergolng lower abdominal surgery, We evaluated their postoperative paln scores uSlng the visual
analogue scale (VAS).
METHODS
After obtainlng approval from our institutional human ethics committee and individual written informed
consent, 60 patients undergolng open lower abdomina一 surgery vI'a infra-unbilical low transverse incision for
benign gynecological disease (total abdominal hysterectomy, myomectomy, or ovarian cystectomy) were
random一y divided vI'a sealed envelope asslgnment into four groups based on the allocation to receive epidural
neostigmine and/or systemic dexmedetomidine as foHows : contro一 (group C), epidural neostigmine (group N),
systemic dexmedetomidine (group D), and co-administered neostigmine and dexmedetomidine (group ND).
Exclusion criteria were age over 50 years, known hypersensitivity to roplVaCaine or neostigmine, patients taking
analgesics preoperatively and pre-existing neurologlCal deficit･ All patients were ASA physical status I or ll and
were instructed on the use of the VAS, comprising a 10-cm 一ine ranging from 0 "no pain at all" to 10 "the worst
possible paln"･ Patients completed this paln assessment P｢eOPeratively and postope｢atively･ The study was
conducted in a prospective, randomized, double-b一ind, placebo-controlled fashion･
premedication was achieved with 7.5 mg zopiclone (ultra-short benzodiazepine receptor acting agent), and
150mg ranitidine orally, prescribed 90min before arrival in the operating room･ An epidural catheter was
placed through a 171gaUge Tuohy needle uslng the loss-of-resistance technique at the Ll-L2 interspace･ After
a negative test dose with 3 ml of O･375% ropivacaine, group C and group D were administered 7 ml of O･375%
roplVaCaine epidurally before the induction of general anesthesia, while group N and group ND were administer
ed 0.3 mg neostigmine added to 7 ml of 0.3750/o ropivacaine･ The dermatomal analgesic Level was evaluated
by uslng an alcohol swab at lOmin after epidural administration･ General anesthesia was induced with
propofol (2 mg/kg), and vecuronium (0.1 mg/kg) was used to facilitate tracheal intubation･ After general
anesthesia was induced, in group D and group ND, a loading dose of dexmedetomidine at 1 /`g/kg i.V. over
10 min was started and followed by a continuous infusion at 0.4JLg/kg/h until the end of surgery･ Dex-
medetomidine (200FLg/2ml) was diluted with 48ml of normal sa=ne, and 50ml of normal saline without
dexmedetomidine was used for placebo. Anesthesia was maintained with 0.7 to 1.5% sevoflurane in 33% 02,
67% N20 (02 : l L/min and N20 : 2 L/min) to maintain the bispectral index values within 45j=5 and intermittent
doses of vecuronium (l to 2 mg) as clinicaHy indicated. Continuous epidural infusion with O･2% ropivacaine at
4ml/h was started at 30min after the start of surgery for 25h. Upon early signs of intraoperative pain
(increasing blood pressure, heart rate, pupil dilation, etc･), additional epidural 0･375% ropivacaine (3 to 5 ml)
was administered, as judged by the anesthesiologist who was b=nded to the study p｢otocol･ Blood p｢essu｢e
was measured every 5 min, and e一ectrocardiogram and hemoglobin oxygen saturation were continuously
monitored throughout surgery. A decrease in mean arterial pressure of more than 20% below the preanesth-
etic baseline value was treated by intravenous increments of ephedrine (4-8 mg) and by intravenous fluid
administration.
For postoperative pain relief, conventional analgesic (drip infusion of 2 mg butorphanol over l h at a
minimum 6 h inteⅣal) ordered by the gynecologist was given according to patient request for 24 h in addition
to the continuous epidural infusion. After the 24 h, 50 mg dicrofenac suppository was ava‖able at a minimum
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4 hours intervaJ.
The postope｢ative paln Status Of patients was assessed at rest uslng VAS scores at 2, 4, 6, 24 and 72 h
postoperatively･ Time for first rescue of analgesics and side effects such as nausea, vomiting and pruritus were
assessed and recorded during the first 24h after surgery･ Nausea and vomiting were treated with 10mg
intravenous metoclopramide upon patient request.
A sample size of 15 patients jn each group was calculated using STATAtm (version 8.0 ; Stata Corporation,
College Station, Tx) to have at least 80% power with a value of 0.0083 (two-sided) in order to detect reduction
of pain scores from 4･0±1.6 to 2.0±0.8 (mean±SD) between the two groups. Those pain scores were chosen
because the reduction of paln scores from 4･O to 2･O is considered clinica"y srgnificant. The data were
analyzed uslng repeated measure analysIS Of variance･ The VAS scores were analyzed uslng KruskaJIWallis
test with subsequent intergroup comparisons made by Mann-Whitney U test with Bonferroni correction. A P
vaJue <0.05 was considered significant.
RESULTS
Patient details, operative duration, total usage amount of 0.375% ropivacaine, dermatomal analgesic lever
and time for first rescue analgesic are summarized in Table l. Additional bolus 0.375% ropivacaine to control
earliest slgn Of pain after surgica=ncision was administered to 2, 2, 1 and 3 patients in group C, N. D and ND,
｢espectively･ No patient ｢equi｢ed further epidural administration of bo仙s 0.375% ropivacaine after the start of
continuous epidural infusion of O･2% ropivacaine. There were no significant differences among the groups.
The types of surglCal procedure performed during the study are shown in Table 2.
Neither intraoperative systemic infusion of dexmedetomidine alone nor epidural neostigmine alone as
analgesic adjuncts to a continuous epidural infusion of roprvacaine reduced the postoperative VAS pain scores.
However, the co-administration of systemic dexmedetomidine and epiduraJ neostigmine slgnificantJy decreased
the VAS scores at 2 h postoperatively (Figurel). Of note. these postoperative analgesic effects were not
observed in the late postoperative period (4-72 h). The VAS scores at all other corresponding times were
simila｢ among the groups th｢oughouHhe obseⅣation period.
TabJel. Summary of Treatment Groups
group C group N group D group ND
Age (y｢)
Body Weight (kg)
Height (cm)
Duration of surgery (min)
Total amount of ropivacalne (ml)
Dermatomal Analgesic level
Time to flrSt rescue analgesICS (h)
Analgesic (butorphanoI)
consumption (mg)
38±8
54±9
157±6
86±32
10.4±1.3
Th7 (6.5-8 [6-9])
7 (3-24 [2-24])
3.0±1.7
36±4
56±13
159±6
93±51
10.6±1.8
Th75 (7-8 [6-8])
10 (6-12 [5-24])
2.1 ±1.6
41±7
51±9
159±5
101 ±40
10.2±1.1
Th7 (7-8 [6-9])
7 (4-19 [2-24])
2.4±1.5
39±7
59±9
160±7
99± 44
11±1.9
Th7 (7-8 [6-9])
8 (3-24 [2-24])
1.7±2.5
Data are expressed as mean±SD or median (InterqUartile range [range]). n-15 There was no significant dlfference among the
groups.
Table2. Operative P｢ocedu｢es Performed
group C group N group D group ND
Total abdominal hysterectomy
Myomectomy
Ovarian cystectomy
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Figure l･ Postoperative VAS scores･ The postoperative paln Status Of patients at rest was assessed uslng the
vAS at 2, 4, 6. 24 and 72h after the end of surgery･ Box represents the 25th175th percentiles･ and
solid =ne represents the median･ Extended bars represent the 一oth-90th pe｢centiles- ∩-15･ VAS
scores were significantly 一ower in group ND compared with group C (*P<0･05)･
Time to first rescue analgesic did not differ among the groups, and analgesic (butorphanol) consumption
during the first 24 h postoperatively was not significantly different among the groups (Tablel). Additional
diclofenac was required by 0, 1, 1 and 0 patient in each group, respectively･
side effects caused by the administration of dexmedetomidine and neostigmine were minima一. Nausea
and vomiting, assessed only by patient complaint without use of a nausea scale･ Were observed in l patient in
group c, 2 in group N, 0 in group D and 1 in group ND･ They either required no treatment, Or were easily
treated with 10 mg metoclopramide (1 patient in group N and 1 in group ND)･ Patients complained of no other
side effects,
DISCUSSl0N
The main findings of this study are that co-administration of systemic dexmedetomidine and epidural
neostigmine resulted in temporary analgesia postoperatively although intraoperative systemic dexmedetomidine
and epidural neostigmine alone did not change postoperative paln SCOre･ No serious side effects caused by
the administration of dexmedetomidine and neostigmine such as hemodynamic changes was observed in any
pat;ents･ A few patients complained nausea and vomiting which required no treatment, or were easily treated･
These results suggest that the co-administration of both intraoperative systemic dexmedetomidine and epidural
neostigmine may be useful for postoperative paln control of patients undergolng lower abdominal surgery under
basal epidural administration of ropivacaine at relatively low doses (0･375%) because of lack of serious side
effects.
The analgesic effects produced by co-administration of systemic dexmedetomidine and epidural neostig-
mine were observed in only early postoperative periods but not late postoperative periods despite our
expectation･ The dose of dexmedetomidine used in this study is recommended dose for sedation in the
intensive care unit as mentioned in the prescribed information･ The half ‥ves of dexmedetomidine at these
doses are reported to be around 2 h whHe the exact pharmacokinetics epidural neostigmine has not been
clarified. The concentration of dexmedetomidine was too low to show ana一gesic interaction with epidural
neostigmine after 4 h postoperatively･
The co-administration of systemic dexmedetomidine and epiduraL neostigmine produced temporary
postoperative analgesic effects･ The dexmedetomidine and neostigmine may interact with each other and have
analgesic effects sim‖ar to those displayed by the co-administration of clonidine and neostigmine12･13) It may
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be an additive or synergistic effect secondary to the different sites and mechanisms of action of dex-
medetomidine and neostigmine. ln the splnal cord. the a2-reCePtOr agOnists produce antinociception by
decreaslng the reJease of glutamate from prlmary afferent nerve terminals14), and by suppresslng the noxiously
evoked activity of wide dynamic range neurons15). On the other hand. neostigmine increases cerebrosplnaI
ACh (acetyfcholine) by inhibiting the breakdown of endogenous ACh in ACh-containing spina一 neurons local-
ized in the superlicial laminae of the dorsal horn of the spinal cord16). The activation of interneurons with ACh-
receptors would, in turn, Lead to increased inhibitory Input Of the secondary sensory afferent neurons17).
Several studies have reported that systemic dexmedetomidine at doses causlng Sedation produced
postoperative analgesic effects, while intraoperative infusion of dexmedetomidine was reported not to change
the VAS scores for postoperative paln. In molar surgery, the intraoperative infusion of dexmedetomidine at
doses causlng Sedation did not result in reduction of paln SCOre18･19). These resuJts are consistent with our data
in this study that dexmedetomidine alone did not decrease in postoperative VAS scores. AIthough the epidural
technique cannot be applied for dental surgery, the use of analgesics which has same mechanisms of action
of neostigmine in paln Pathway in dento10ral area could improve postoperative paln Status When co-administer-
ed with dexmedetomisine.
The continuous epidural technique was employed for per10Perative analgesia in this study. We selected
this approach because continuous epidural analgesia is a simple, efficient and conventional technique for open
abdominal surgery. The epidural infusion could partially account for the insufficient postoperative analgesic
effects of the dexmedetomidine and neostigmine at 4, 6. 24 h postoperativeFy. The basal epidural analgesaia
with 0.375% ropivacaine foHowed by continuous infusion of 0.2%　ropivacaine may block incisional and
州ammatory stimu山s to some extent, and masks antinociceptive effects of the dexmedetomidine and neostig-
mine. ln addition, the residual ana一gesic effects of the 10 ml of 0.375% ropivacaine at the start of surgery and
the diminished stimulus produced by surglCal incision and followed inflammatory responses could explain the
rower paln scores at 2 and 72 h postoperatively ln all groups. respectively.
There are limitations to this study. We examined the effects of a slngle dose of dexmedetomidine, of
neostigmine and of one combination. lt has been demonstrated that higher doses of dexmedetomidine than
those causlng Sedation result in analgesic effectsl), and high doses of dexmedetomidine have been used as total
intravenous anesthesia (TIVA)20). The dose of 0.3mg neostigmine was selected in consultation with the
previous studieslO). The doses of 0.5-0.7 mg of neostigmine demonstrated more satisfactory results21,22). In
addition, in the present study we administered dexmedetomidine only intraoperatively and not postoperatively.
The postoperative administration of dexmedetomidine after thoracic surgery was found to decrease VAS scores
for pain in the early postoperative period and decrease the requirements for supplemental epidural fentanyl23).
The lowe｢ dose was chosen due to fear for side effects. Altemative approaches such as higher doses of
dexmedetomidine and neostigmine and/or continuous intra- and postoperative infusion may improve pos-
tope｢ative paln Status.
ln conclusion, the co-administration of systemic dexmedetomidine and epidural neostigmine resulted in
temporary analgesia postoperatively under basal epidural administration of ropIVaCaine at relatively low doses
(0.375%). Because of lack of serious side effects, this approach may be useful to improve postoperative pain
although additional studies are necessary to evaluate the effectiveness of the co-administration of dex-
medetomidine and neostigmine.
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